The protein transthyretin can change shape and clump together. Drugs for hATTR with polyneuropathy target this troublemaker.
Treatments for hereditary transthyretin amyloidosis with polyneuropathy were once limited, but new therapies improve symptoms of the rare disease.
Treatments for hereditary transthyretin amyloidosis (hATTR) with polyneuropathy were once limited, but there’s progress to slow the disease’s progression.
Hereditary transthyretin amyloidosis (hATTR) is a very rare disease with symptoms that make it hard to take care of yourself. But these tips can help.
Hereditary transthyretin amyloidosis (hATTR) with polyneuropathy is rare, but with diagnosis through genetic testing, you can find answers and treatment.
A look at how hATTR advances, and working with your doctor to get palliative and end-of-life care.
